Canadian investment into Bourn Hall

UK-based fertility clinic specialist Bourn Hall has secured "significant investment" from Triangle Capital Corporation, a Canadian-based investment firm.

Metropolis buys big in India, targets further growth

India-based lab group Metropolis Healthcare has bought big in South India, acquiring a network of 31 laboratories and 68 collection centres to its network. The combined entity confirms its position as the second-largest diagnostics company in India and the largest brand in South and West India. Further acquisitions by large Indian diagnostics players are expected.

Appointment of new Artemis CEO lends weight to sale rumours

The CEO of Artemis Group, Germany's second largest ophthalmology chain by revenue, is stepping down from his position as CEO next week to be replaced by the former MD of German rehabilitation specialist Median Kliniken, who is also an ex McKinsey & Company consultant and investment house managing director. A source tells us this is being done in anticipation of a sale.

Muted electronic patient record rollout in Germany

Just 2% of publicly insured Germans have registered to see their electronic patient record (ePA) since access was made mandatory at the beginning of the year. Many either don't know it exists or are worried about data privacy, HBI hears. That settles some answers to the question of whether it's worthwhile giving patients access to their own data.

Biogroup ‘buying’ €100m French lab

France's largest lab group Biogroup is reportedly continuing its consolidation of the French market and in exclusive negotiations to acquire much smaller competitor Oriade Noviale.

Rede d’Or’s payors losing market cap

Analysts covering Brazil's largest private hospital Rede d'Or have projected a 25% rise share price after its $2.2bn IPO last month. However, the sustainability of its fee-for-service business model in the long-term has been questioned by some. Its insurers are slowly losing market cap to integrated players.

Goodgrower buys back 20% Vithas stake, with HM merger “impossible”

Spain's second-largest for-profit hospital chain Vithas will be 100% owned by the founding Gallardo family after their family office Goodgrower agreed to buy the 20% stake held by Criteria Caixa, a bank investment arm. What does it mean for Vithas' M&A plans and the rumoured merger with rival HM Hospitales? We talk to a Spanish advisor.

UHCG faces tough call in Brazil

Amy Shaw, the incoming CEO of UnitedHealthcare Global (UHCG), the world's largest owner of for-profit hospitals in emerging markets, faces tough choices. UHCG, the international arm of US insurer UnitedHealth, has a colossal headache in Brazil, by far its largest market. For instance, reports suggest UHCG may have to pay R$1bn to shift its personal policy portfolio in a deal which has already been sweetened by the addition of several hospitals. There is speculation that, like Cigna in the 1990s, which wrote off some US$500m on medical plan Golden Cross, that UnitedHealth may decide to exit Brazil completely. A full pull-out looks unlikely, but the full year 2020 results to be announced on Wednesday, January 20 may well see big write-offs. 

Ramsay Sime Darby targeting $300m spin-off IPO

HBI understands that Malaysian/Indonesian hospital group Ramsay Sime Darby has appointed banks for a $300m IPO. One side of the JV says that expansion in healthcare is a key strategic focus, the other appears notably quiet about its investment in Asia. FY2020 saw profits drop for "the first time in many years" as COVID struck.

Find Us